The Sickle Cell Disease Market Share is divided among pharmaceutical giants, biotech innovators, and research organizations, each contributing to advancements in patient care. Large companies hold significant shares due to their strong R&D investments, wide distribution networks, and ability to fund clinical trials for groundbreaking therapies like gene editing. Smaller biotech firms,...